Skip to main content
search
Category

Highlights Archive

HighlightsHighlights Archive

New AI tool quickly rules out heart attacks in A&E patients

A new AI tool developed in the UK, named Rapid-RO, can quickly rule out heart attacks in A&E patients, potentially reducing unnecessary hospital stays. During trials, it accurately ruled out heart attacks in over a third of patients, outperforming traditional troponin blood tests. Patients often require multiple troponin tests during their stay, however, Rapid-RO requires just one. The AI uses…
Ben Kemp
June 11, 2024
HighlightsHighlights Archive

Media Monitoring: May 30 – June 5

An update on the ongoing NHS-Galleri trial Based on data from the first year of the three-year NHS-Galleri trial, NHS England has decided that it will wait to see final results, expected in 2026, before considering whether an NHS rollout of the Galleri multi cancer early detection test (the Multi Cancer Blood Test Programme, MCBT) should go ahead. Many successful…
Ben Kemp
June 5, 2024
HighlightsHighlights Archive

Blood test predicts return of breast cancer

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to detect the presence of tiny amounts of cancer DNA left in the body following treatment for early breast cancer.…
Ben Kemp
June 5, 2024
HighlightsHighlights Archive

Thousands set to benefit from personalised cancer vaccines

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial “matchmaking” service to help find new life-saving treatments. The NHS announced it has treated its first patient in England with a personalised vaccine against their bowel cancer, in a clinical trial part of NHS…
Ben Kemp
June 5, 2024
HighlightsHighlights Archive

Media Monitoring: 23 – 29 May

Driving action on antimicrobial resistance (AMR) in 2024 This policy brief from the Wellcome Trust identifies opportunities to drive change in how governments respond collaboratively to antimicrobial resistance (AMR), with 3 recommendations: Countries should use the Political Declaration of the High-Level Meeting in September to set a bold, unifying goal for a reduction in the global burden of AMR. The…
Ben Kemp
May 28, 2024
HighlightsHighlights Archive

NHS patients favour shift of focus to primary care, prevention and earlier diagnosis – report

A Health Foundation report examining the public's view of the future of the NHS has found support for a shift towards a focus on primary care, prevention and earlier diagnosis. Participants acknowledged the NHS's tight finances, stating they would prefer primary and community care prioritised as a means of preventing ill health and therefore keeping patients out of hospital. They…
Ben Kemp
May 28, 2024
HighlightsHighlights Archive

Media Monitoring: 16 – 22 May

Proteins in blood could provide early cancer warning ‘by more than seven years’ Proteins in the blood could warn people of cancer more than seven years before it is diagnosed, according to research. Scientists at the University of Oxford studied blood samples from more than 44,000 people in the UK Biobank, including over 4,900 people who subsequently had a cancer…
Ben Kemp
May 22, 2024
HighlightsHighlights Archive

NHSE South East data provides evidence of virtual ward benefits

A large-scale evaluation of virtual wards in South East England has found the scheme saves money and prevents hospital admissions. NHS England South East region commissioned an independent evaluation from PPL to fill the critical large-scale evidence gap on virtual wards, offering actionable insights for healthcare providers, policymakers, and researchers. The evaluation analysed a total of 29 virtual ward pathways…
Ben Kemp
May 22, 2024
HighlightsHighlights Archive

Fleming Initiative boosted by £45m GSK investment

GSK will become the first partner of the new Imperial-led Fleming Initiative, which aims to tackle antimicrobial resistance globally. Global biopharma company GSK will become the first founding partner of the Fleming Initiative, an innovative and collaborative new approach led by Imperial College London and Imperial College Healthcare NHS Trust and to tackle antimicrobial resistance (AMR) around the world. A £45m pledge…
Ben Kemp
May 22, 2024
Close Menu